Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Kevin Koch > Profile

Kevin Koch

Affiliations

  • President And Ceo at Edgewise Therapeutics Inc. (EWTX), 2025-05-08
  • Director at Miragen Therapeutics Inc. (MGEN), 2020-05-22
  • President, Cso at Array Biopharma Inc (ARRY), 2013-08-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EWTX $16.45 4,276 $70,358.16 20,619 2025-05-02 Filing
EWTX $30.00 100 $3,000.00 14,478 2025-03-07 Filing
EWTX $31.13 900 $28,017.99 14,478 2025-02-06 Filing
EWTX $30.03 8,636 $259,297.63 14,478 2025-02-05 Filing
EWTX $18.91 3,152 $59,604.32 14,478 2024-05-02 Filing